Filed
by the Registrant þ
|
|
Filed
by a Party other than the Registrant o
|
|
Check
the appropriate box:
|
|
o
|
Preliminary
Proxy Statement
|
o
|
Confidential,
for Use of the Commission Only (as permitted by
Rule 14a-6(e)(2))
|
þ
|
Definitive
Proxy Statement
|
o
|
Definitive
Additional Materials
|
o
|
Soliciting
Material Pursuant to §240.14a-12
|
RBC
BEARINGS INCORPORATED
|
||
(Name
of Registrant as Specified In Its Charter)
|
||
|
||
(Name
of Person(s) Filing Proxy Statement, if other than the
Registrant)
|
||
|
||
Payment
of Filing Fee (Check the appropriate box):
|
||
þ
|
No
fee required.
|
|
o
|
Fee
computed on table below per Exchange Act
Rules 14a-6(i)(1) and 0-11.
|
|
|
(1)
|
Title
of each class of securities to which transaction
applies:
|
|
|
|
|
(2)
|
Aggregate
number of securities to which transaction applies:
|
|
|
|
|
(3)
|
Per
unit price or other underlying value of transaction computed pursuant
to
Exchange Act Rule 0-11 (set forth the amount on which the filing fee
is calculated and state how it was determined):
|
|
|
|
|
(4)
|
Proposed
maximum aggregate value of transaction:
|
|
|
|
|
(5)
|
Total
fee paid:
|
|
|
|
o
|
Fee
paid previously with preliminary materials.
|
|
o
|
Check
box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its
filing.
|
|
|
(1)
|
Amount
Previously Paid:
|
|
|
|
|
(2)
|
Form,
Schedule or Registration Statement No.:
|
|
|
|
|
(3)
|
Filing
Party:
|
|
|
|
|
(4)
|
Date
Filed:
|
|
|
|
|
|
|
(1) |
the
election of three directors to serve a term of three
years;
|
(2) |
the
ratification of the appointment of Ernst & Young LLP as our
independent registered public accounting firm for fiscal 2009;
and
|
(3) |
any
other matter that may properly come before the meeting or any adjournment
or postponement thereof.
|
By
order of the Board of Directors,
|
Chairman
and Chief Executive Officer
|
|
The
Board recommends a vote
FOR
the election to the Board Of Directors of the nominees listed
above.
|
|
|
The
Board recommends a vote
FOR
the ratification of the appointment of ERNST & YOUNG LLP as the
Company’s independent auditors for fiscal
2009.
|
|
DIRECTOR
COMPENSATION
|
||||||||||||||||||||||
Fees
Earned
or
Paid
in
Cash
|
Stock
Awards
|
Option
Awards
|
Non-Equity
Incentive Plan Compensation
|
Change
in Pension Value and Nonqualified Deferred Compensation
Earnings
|
All
Other Compensation
|
Total
|
||||||||||||||||
Name
|
($)
|
($)(1)
|
($)(2)
|
($)
|
($)
|
($)
|
($)
|
|||||||||||||||
Richard
Crowell
|
55,000
|
4,569
|
7,429
|
-
|
-
|
-
|
66,998
|
|||||||||||||||
Dr.
Amir Faghri
|
50,000
|
4,569
|
7,429
|
-
|
-
|
-
|
61,998
|
|||||||||||||||
William
Killian
|
50,000
|
4,569
|
7,429
|
-
|
-
|
-
|
61,998
|
|||||||||||||||
Alan
B. Levine
|
55,000
|
4,569
|
7,429
|
-
|
-
|
-
|
66,998
|
|||||||||||||||
Dr.
Thomas J. O’Brien
|
50,000
|
4,569
|
7,429
|
-
|
-
|
-
|
61,998
|
(1)
|
These
amounts reflect the dollar amount recognized for financial reporting
purposes for the fiscal year ended March 29, 2008 in accordance with
Statement of Financial Accounting Standards, or SFAS, No. 123(R)
for 500
restricted stock units (representing the right to receive 500 shares
of
common stock upon vesting) granted on July 13, 2006 and for 1,000
restricted stock units (representing the right to receive 1,000 shares
of
common stock upon vesting) granted on February 12,
2008.
|
(2)
|
These
amounts reflect the dollar amount recognized for financial reporting
purposes for the fiscal year ended March 29, 2008 in accordance with
Statement of Financial Accounting Standards, or SFAS, No. 123(R)
for 2,500
options granted on July 13, 2006 and 2,500 options granted on February
12,
2008.
|
Name of Beneficial Owner
|
Amount and Nature of
Beneficial Ownership
|
Percent of Class
|
|||||
Dr. Michael
J. Hartnett
|
919,009
|
4.2
|
%
|
||||
Daniel
A. Bergeron
|
19,585
|
*
|
|||||
Phillip
H. Beausoleil
|
25,142
|
*
|
|||||
Thomas
C. Crainer
|
28,185
|
*
|
|||||
Richard
J. Edwards
|
34,598
|
*
|
|||||
Richard
R. Crowell
|
49,426
|
*
|
|||||
Dr. Amir
Faghri
|
8,166
|
*
|
|||||
William
P. Killian
|
5,666
|
*
|
|||||
Alan
B. Levine
|
6,166
|
*
|
|||||
Dr. Thomas
J. O’Brien
|
9,666
|
*
|
|||||
All
directors and executive officers as a group (12 persons)
|
1,124,430
|
5.2
|
%
|
Name and Address of Beneficial Owner
|
Amount and Nature of Beneficial
Ownership
|
Percent of Class
|
|||||
Westfield
Capital Management Company, LLC
|
1,635,163
|
(a)
|
7.6
|
%
|
|||
One
Financial Center, 24th Floor
|
|||||||
Boston,
MA 02111-2690
|
|||||||
T.
Rowe Price Associates, Inc. 100 East Pratt Street
|
1,293,100
|
(b)
|
6
|
%
|
|||
100
East Pratt Street
|
|||||||
Baltimore,
MD 21202-1009
|
Name
|
Age
|
|
Positions
|
|||
Dr. Michael
J. Hartnett
|
62
|
|
Chairman,
President and Chief Executive Officer
|
|||
Daniel
A. Bergeron
|
48
|
|
Vice
President, Chief Financial Officer and Assistant
Secretary
|
|||
Phillip
H. Beausoleil (1)
|
64
|
|
General
Manager
|
|||
Thomas
C. Crainer
|
50
|
|
Vice
President and General Manager
|
|||
Richard
J. Edwards
|
52
|
|
Vice
President and General Manager
|
|||
Thomas
J. Williams
|
56
|
Corporate
General Counsel & Secretary
|
||||
Thomas
Burigo
|
56
|
Corporate
Controller
|
||||
Richard
R. Crowell
|
53
|
|
Director
|
|||
Dr. Amir
Faghri
|
56
|
|
Director
|
|||
William
P. Killian
|
73
|
|
Director
|
|||
Alan
B. Levine
|
64
|
|
Director
|
|||
Dr. Thomas
J. O’Brien
|
60
|
|
Director
|
|
•
|
|
have
an exercise price equal to the fair market value of common stock
on the
date of grant;
|
|
|
||
|
•
|
|
typically
vest over a three to five-year period in equal amounts each year;
and
|
|
|
||
|
•
|
|
expire
seven years after the date of grant.
|
SUMMARY
COMPENSATION
|
||||||||||||||||||||||||||||
Change
in
|
||||||||||||||||||||||||||||
Pension Value
|
||||||||||||||||||||||||||||
and
|
||||||||||||||||||||||||||||
Nonqualified
|
||||||||||||||||||||||||||||
Non-Equity
|
Deferred
|
|||||||||||||||||||||||||||
Stock
|
Option
|
Incentive
Plan
|
Compensation
|
All
Other
|
||||||||||||||||||||||||
Salary
|
Bonus
|
Awards
|
Awards
|
Compensation
|
Earnings
|
Compensation
|
Total
|
|||||||||||||||||||||
Name
and Principal Position
|
Year
|
($)
|
($)
|
($)
|
($)
|
($)
|
($)
|
($)
|
($)
|
|||||||||||||||||||
(a)
|
(b)
|
(c)(1)
|
(d)(2)
|
(e)(3)
|
(f)(3)
|
(g)(4)
|
(h)
|
(i)
|
(j)
|
|||||||||||||||||||
Dr.
Michael J. Hartnett
|
2008
|
635,506
|
-
|
102,130
|
152,475
|
-
(10
|
)
|
-
|
103,489
(5
|
)
|
993,600
|
|||||||||||||||||
2007
|
605,244
|
-
|
56,650
|
82,500
|
1,250,176
|
-
|
59,893
(5
|
)
|
2,054,463
|
|||||||||||||||||||
Daniel
A. Bergeron
|
2008
|
245,500
|
-
|
25,852
|
61,775
|
-
(10
|
)
|
-
|
18,324
(6
|
)
|
351,451
|
|||||||||||||||||
2007
|
229,000
|
-
|
16,995
|
39,960
|
145,000
|
-
|
13,200
(6
|
)
|
444,155
|
|||||||||||||||||||
Phillip
H. Beausoleil
|
2008
|
249,050
|
-
|
22,660
|
35,520
|
-
(10
|
)
|
-
|
19,144
(7
|
)
|
326,374
|
|||||||||||||||||
2007
|
238,900
|
-
|
16,995
|
26,640
|
125,000
|
-
|
15,452
(7
|
)
|
422,987
|
|||||||||||||||||||
Thomas
C. Crainer
|
2008
|
221,750
|
-
|
25,852
|
46,139
|
-
(10
|
)
|
-
|
25,957
(8
|
)
|
319,698
|
|||||||||||||||||
2007
|
210,000
|
-
|
16,995
|
26,640
|
174,900
|
-
|
20,144
(8
|
)
|
448,679
|
|||||||||||||||||||
Richard
J. Edwards
|
2008
|
238,333
|
-
|
24,788
|
40,617
|
-
(10
|
)
|
-
|
20,950
(9
|
)
|
324,688
|
|||||||||||||||||
2007
|
227,417
|
-
|
16,995
|
26,640
|
91,875
|
-
|
12,850
(9
|
)
|
375,777
|
(1)
|
Column
(c) includes amounts deferred by the officer pursuant to a 401(k)
Plan.
|
(2)
|
Bonuses
for fiscal 2008 and fiscal 2007 were paid under the Company’s incentive
compensation plan and are reflected in column
(g).
|
(3)
|
The
amounts in columns (e) and (f) reflect the dollar amount recognized
for
financial statement reporting purposes for the fiscal years ended
March
29, 2008 and March 31, 2007, as applicable, in accordance with SFAS
No.
123(R) of stock options and restricted stock units granted under
the 2005
Long-Term Equity Incentive Plan and thus may include amounts from
awards
granted in and prior to such years. Assumptions used in the calculation
of
these amounts are included in Note 16 to the Company’s audited
consolidated financial statements for the fiscal year ended March
29, 2008
included in the Company’s Annual Report on Form 10-K filed with the
Securities and Exchange Commission on May 28,
2008.
|
(4)
|
The
amounts in column (g) consist of annual cash bonuses earned in fiscal
2008
and fiscal 2007 and paid in the following fiscal year under the Company’s
incentive compensation plan.
|
(5)
|
Consists
of a leased vehicle of $3,580 in fiscal 2008 and $3,639 in fiscal
2007,
employee match contributed to Dr. Hartnett’s SERP account of $43,756 in
fiscal 2008 and $56,254 in fiscal 2007, Company-paid life insurance
premiums of $29,100 in fiscal 2008, and reimbursement of personal
expenses
per Dr. Hartnett’s employment agreement of $27,053 in fiscal
2008.
|
(6)
|
Consists
of a vehicle allowance of $6,000 in fiscal 2008 and fiscal 2007 and
employer match contributed to Mr. Bergeron’s SERP account of $12,324 in
fiscal 2008 and $7,200 in fiscal
2007.
|
(7)
|
Consists
of employer match contributed to Mr. Beausoleil’s 401(k) account of $5,407
in fiscal 2008 and $2,245 in fiscal 2007, employer match contributed
to
Mr. Beausoleil’s SERP account of $13,092 in fiscal 2008 and $12,562 in
fiscal 2007, and Company-paid life insurance premiums of $645 in
fiscal
2008 and fiscal 2007.
|
(8)
|
Consists
of employer match contributed to Mr. Crainer’s 401(k) account of $5,848 in
fiscal 2008 and $2,280 in fiscal 2007, employer match contributed
to Mr.
Crainer’s SERP account of $13,122 in fiscal 2008 and $10,750 in fiscal
2007, Company-paid life insurance premiums of $783 in fiscal 2008
and
fiscal 2007, a leased vehicle of $1,204 in fiscal 2008 and $930 in
fiscal
2007, healthcare expense reimbursements of $5,000 in fiscal 2008,
and
relocation reimbursements of $5,401 in fiscal
2007.
|
(9)
|
Consists
of employer match contributed to Mr. Edwards’s 401(k) account of $4,372 in
fiscal 2008 and $2,409 in fiscal 2007, employer match contributed
to Mr.
Edwards’ SERP account of $5,128 in fiscal 2008 and $3,750 in fiscal 2007,
Company-paid life insurance premiums of $1,805 in fiscal 2008 and
fiscal
2007, and a leased vehicle of $9,645 in fiscal 2008 and $4,886 in
fiscal
2007.
|
(10)
|
To
be determined at next meeting of Compensation Committee scheduled
for July
29, 2008.
|
GRANTS
OF PLAN-BASED AWARDS
|
||||||||||||||||||||||||||||||||||
Estimated Future Payouts
Under Non-Equity Incentive
Plan Awards
|
Estimated Future Payouts
Under Equity Incentive
Plan Awards
|
All Other
Stock Awards:
Number
of Shares
of
Stock or
Units
|
All Other
Option Awards:
Number of
Securities Underlying Options
|
Exercise or
Base Price of Option Awards
|
Grant Date
Fair Value of Stock and Stock Option
Awards
|
|||||||||||||||||||||||||||||
Grant
|
Threshold
|
Target
|
Maximum
|
Threshold
|
Target
|
Maximum
|
||||||||||||||||||||||||||||
Name
|
Date
|
($)
|
($)
|
($)
|
(#)
|
(#)
|
(#)
|
(#)(8)
|
(#)
|
($/Sh)
|
($)(9)
|
|||||||||||||||||||||||
Dr.
Michael J. Hartnett
|
-
|
|
(1)
|
656,342
|
(2)
|
1,312,684
|
(3)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||
|
2/12/2008
|
-
|
-
|
-
|
-
|
-
|
-
|
25,000
|
-
|
-
|
797,750
|
|||||||||||||||||||||||
|
2/12/2008
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
100,000
|
31.91
|
1,274,000
|
|||||||||||||||||||||||
Daniel
A. Bergeron
|
-
|
|
(4)
|
125,000
|
(5)
|
156,250
|
(6)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||
|
2/12/2008 |
-
|
-
|
-
|
-
|
-
|
-
|
3,000
|
-
|
-
|
95,750
|
|||||||||||||||||||||||
|
2/12/2008 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
20,000
|
31.91
|
254,800
|
|||||||||||||||||||||||
Phillip
H. Beausoleil
|
-
|
-
|
150,000
|
(7)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||
|
2/12/2008
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||||
|
2/12/2008
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||||
Thomas
C. Crainer
|
-
|
-
|
135,000
|
(7)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||
|
2/12/2008 |
-
|
-
|
-
|
-
|
-
|
-
|
3,000
|
-
|
-
|
95,750
|
|||||||||||||||||||||||
|
2/12/2008
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
25,000
|
31.91
|
318,500
|
|||||||||||||||||||||||
Richard
J. Edwards
|
-
|
-
|
147,000
|
(7)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||
|
2/12/2008 |
-
|
-
|
-
|
-
|
-
|
-
|
2,000
|
-
|
-
|
63,820
|
|||||||||||||||||||||||
|
2/12/2008
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
12,000
|
31.91
|
152,880
|
(1)
|
Under
the Annual Incentive Compensation Plan, if the target is not met,
the
amount of the award is at the discretion of the Board of
Directors.
|
(2)
|
Equals
100% of base salary (90% to 99.9% of EBITDA to
plan).
|
(3)
|
Equals
200% of base salary (110% or greater of EBITDA to plan). (Would equal
150%
of base salary if 100% to 109.9% of EDITDA to
plan).
|
(4)
|
If
the target is not met, the amount of the award is at the discretion
of the
CEO.
|
(5)
|
Equals
50% of base salary (90% to 104.9% of EBITDA to
plan).
|
(6)
|
Equals
125% of target (105% or higher of EBITDA to
plan).
|
(7)
|
Target
is 60% of base salary. The targeted percentage is made up of three
elements: (1) thirty percent of base salary upon achieving one hundred
percent of the established annual revenue and profit plan, with a
minimum
threshold of more than eighty percent of plan, with an opportunity
to earn
up to sixty percent of base salary if the achievement is equal to
one
hundred and twenty percent; (2) up to fifteen percent of base salary
based
on year to year revenue growth achievement in excess of two time
Gross
Domestic Product; and (3) an up to fifteen percent of base salary,
at the
discretion of the CEO, upon achievement of acceptable customer service
levels, development of human resources and the Company’s overall
performance.
|
(8)
|
Awarded
under the 2005 Long-Term Equity Incentive Program. The Grant Date
Fair
Value is based on the grant date closing price of
$31.91.
|
(9)
|
Awarded
under the 2005 Long-Term Equity Incentive Program. The Grant Date
Fair
Value is based on assumptions described in Note 16 to the Company’s
audited consolidated financial statements for the fiscal year ended
March
29, 2008 included in the Company’s Annual Report on Form 10-K filed with
the Securities and Exchange Commission on May 28, 2008. The weighted
average fair value per share of options granted in fiscal 2008 was
$12.74.
|
OPTION AWARDS
|
STOCK AWARDS
|
|||||||||||||||||||||||||||
Number of
Securities
Underlying
Unexercised
Options
|
Number of
Securities
Underlying
Unexercised
Options
|
Equity
Incentive
Plan
Awards:
Number of
Securities
Underlying
Unexercised
Unearned
Options
|
Option
Exercise
Price
|
Option
Expiration
Date
|
Number of
Shares or
Units of
Stock That
Have Not
Vested
|
Market
Value of
Shares or
Units of
Stock
That
Have Not
Vested
|
Equity Incentive
Plan Awards:
Number of
Unearned
Shares, Units or
Other Rights
That Have Not
Vested
|
Equity Incentive
Plan Awards:
Market or
Payout Value of
Unearned
Shares, Units or
Other Rights
That Have Not
Vested
|
||||||||||||||||||||
(#)
|
(#)
|
(#)
|
($)
|
(#)
|
($)(1)
|
(#)
|
($)
|
|||||||||||||||||||||
Name
|
Exercisable
|
Unexercisable
|
||||||||||||||||||||||||||
Dr.
Michael J. Hartnett
|
533,502
|
-
|
-
|
14.50
|
8/10/2015
|
-
|
-
|
-
|
-
|
|||||||||||||||||||
13,333
|
26,667
(2
|
)
|
-
|
22.66
|
7/12/2013
|
-
|
-
|
-
|
-
|
|||||||||||||||||||
|
- |
100,000
(3
|
)
|
-
|
31.91
|
2/12/2015
|
-
|
-
|
-
|
-
|
||||||||||||||||||
|
- |
-
|
-
|
-
|
-
|
6,667
(9
|
)
|
241,279
|
-
|
-
|
||||||||||||||||||
|
- |
-
|
-
|
-
|
-
|
25,000
(10
|
)
|
904,750
|
-
|
-
|
||||||||||||||||||
Daniel
A. Bergeron
|
6,000
|
24,000
(4
|
)
|
-
|
22.66
|
7/12/2013
|
-
|
-
|
-
|
-
|
||||||||||||||||||
|
- |
20,000
(5
|
)
|
-
|
31.91
|
2/12/2015
|
-
|
-
|
-
|
-
|
||||||||||||||||||
|
- |
-
|
-
|
-
|
-
|
4,000
(11
|
)
|
144,760
|
-
|
-
|
||||||||||||||||||
|
- |
-
|
-
|
-
|
-
|
3,000
(12
|
)
|
108,570
|
-
|
-
|
||||||||||||||||||
- | ||||||||||||||||||||||||||||
Phillip
H. Beausoleil
|
12,500
|
-
|
-
|
12.00
|
7/1/2012
|
-
|
-
|
-
|
-
|
|||||||||||||||||||
4,000
|
16,000
(6
|
)
|
-
|
22.66
|
7/12/2013
|
-
|
-
|
-
|
-
|
|||||||||||||||||||
|
- |
-
|
-
|
-
|
-
|
4,000
(11
|
)
|
144,760
|
-
|
-
|
||||||||||||||||||
- | ||||||||||||||||||||||||||||
Thomas
C. Crainer
|
12,500
|
-
|
-
|
12.00
|
7/1/2012
|
-
|
-
|
-
|
-
|
|||||||||||||||||||
4,000
|
16,000
(6
|
)
|
-
|
22.66
|
7/12/2013
|
-
|
-
|
-
|
-
|
|||||||||||||||||||
|
- |
25,000
(7
|
)
|
-
|
31.91
|
2/12/2015
|
-
|
-
|
-
|
-
|
||||||||||||||||||
|
- |
-
|
-
|
-
|
-
|
4,000
(11
|
)
|
144,760
|
-
|
-
|
||||||||||||||||||
|
- |
-
|
-
|
-
|
-
|
3,000
(12
|
)
|
108,570
|
-
|
-
|
||||||||||||||||||
Richard
J. Edwards
|
7,500
|
-
|
-
|
8.00
|
3/19/2014
|
-
|
-
|
-
|
-
|
|||||||||||||||||||
12,500
|
-
|
-
|
12.00
|
7/1/2012
|
-
|
-
|
-
|
-
|
||||||||||||||||||||
4,000
|
16,000
(6
|
)
|
-
|
22.66
|
7/12/2013
|
-
|
-
|
-
|
-
|
|||||||||||||||||||
|
- |
12,000
(8
|
)
|
-
|
31.91
|
2/12/2015
|
-
|
-
|
-
|
-
|
||||||||||||||||||
|
- |
-
|
-
|
-
|
-
|
4,000
(11
|
)
|
144,760
|
-
|
-
|
||||||||||||||||||
|
- |
-
|
-
|
-
|
-
|
2,000
(13
|
)
|
72,380
|
-
|
-
|
(1) |
These
amounts are based on a price per share of $36.19, the closing sales
price
for a share of our common stock on the last business day of fiscal
2008
(March 28, 2008) as quoted by the Nasdaq National
Market.
|
(2) |
These
options vest as follows: 13,333 on July 12, 2008 and 13,334 on July
12,
2009.
|
(3) |
These
options vest as follows: 20,000 on February 12, 2009, 20,000 on February
12, 2010, 20,000 on February 12, 2011, 20,000 on February 12, 2012
and
20,000 on February 12, 2013.
|
(4) |
These
options vest as follows: 6,000 on July 12, 2008, 6,000 on July 12,
2009,
6,000 on July 12, 2010 and 6,000 on July 12,
2011.
|
(5) |
These
options vest as follows: 4,000 on February 12, 2009, 4,000 on February
12,
2010, 4,000 on February 12, 2011, 4,000 on February 12, 2012, and
4,000 on
February 12, 2013.
|
(6) |
These
options vest as follows: 4,000 on July 12, 2008, 4,000 on July 12,
2009,
4,000 on July 12, 2010 and 4,000 on July 12,
2011.
|
(7) |
These
options vest as follows: 5,000 on February 12, 2009, 5,000 on February
12,
2010, 5,000 on February 12, 2011, 5,000 on February 12, 2012, and
5,000 on
February 12, 2013.
|
(8) |
These
options vest as follows: 2,400 on February 12, 2009, 2,400 on February
12,
2010, 2,400 on February 12, 2011, 2,400 on February 12, 2012, and
2,400 on
February 12, 2013.
|
(9) |
These
restricted stock awards vest as follows: 3,333 on July 12, 2008 and
3,334
on July 12, 2009.
|
(10) |
These
restricted stock awards vest as follows: 5,000 on February 12, 2009,
5,000
on February 12, 2010, 5,000 on February 12, 2011, 5,000 on February
12,
2012, and 5,000 on February 12,
2013.
|
(11) |
These
restricted stock awards vest as follows: 1,000 on July 12, 2008,
1,000 on
July 12, 2009, 1,000 on July 12, 2010 and 1,000 on July 12,
2011.
|
(12) |
These
restricted stock awards vest as follows: 600 on February 12, 2009,
600 on
February 12, 2010, 600 on February 12, 2011, 600 on February 12,
2012, and
600 on February 12, 2013.
|
(13) |
These
restricted stock awards vest as follows: 400 on February 12, 2009,
400 on
February 12, 2010, 400 on February 12, 2011, 400 on February 12,
2012, and
400 on February 12, 2013.
|
OPTION AWARDS
|
STOCK AWARDS
|
||||||||||||
Number of
Shares
Acquired on
Exercise
|
Value Realized
on Exercise
|
Number of
Shares
Acquired on
Vesting
|
Value
Realized on
Vesting
|
||||||||||
Name
|
(#)
|
|
($)(1)
|
|
(#)
|
|
($)(4)
|
|
|||||
Dr.
Michael J. Hartnett
|
150,000
|
2,161,500
|
(2)
|
3,333
|
139,953
|
||||||||
Daniel
A. Bergeron
|
-
|
-
|
1,000
|
41,990
|
|||||||||
Phillip
H. Beausoleil
|
10,000
|
286,178
|
(3)
|
1,000
|
41,990
|
||||||||
5,000
|
150,239
|
(3)
|
-
|
-
|
|||||||||
Thomas
C. Crainer
|
7,300
|
292,255
|
(3)
|
1,000
|
41,990
|
||||||||
2,674
|
106,821
|
(3)
|
-
|
-
|
|||||||||
4,026
|
160,798
|
(3)
|
-
|
-
|
|||||||||
Richard
J. Edwards
|
7,500
|
243,317
|
(3)
|
1,000
|
41,990
|
(1) |
The
value realized represents the difference between the fair market
value of
the shares of common stock acquired on the date of exercise and the
aggregate exercise price for such
options.
|
(2) |
The
fair market value was based on the closing price of our common stock
on
the date of exercise as quoted by the Nasdaq National
Market.
|
(3) |
The
fair market value was based on the actual price received on the sale
of
the common stock issued on the date of
exercise.
|
(4) |
The
fair market value was based on the closing price of our common stock
on
the date of vesting.
|
Executive
Contributions
in Last Fiscal
Year
|
Registrant
Contributions
in Last Fiscal
Year
|
Aggregate
Earnings in
Last Fiscal
Year
|
Aggregate
Withdrawals/
Distributions
|
Aggregate
Balance at
Last Fiscal
Year End
|
||||||||||||
Name
|
($)(1)
|
($)(2)
|
($)(3)
|
($)
|
($)
|
|||||||||||
Dr.
Michael J. Hartnett
|
87,512
|
43,756
|
49,803
|
-
|
1,090,282
|
|||||||||||
Daniel
A. Bergeron
|
24,648
|
12,324
|
(13,321
|
)
|
-
|
78,440
|
||||||||||
Phillip
H. Beausoleil
|
37,405
|
13,092
|
2,603
|
-
|
404,261
|
|||||||||||
Thomas
C. Crainer
|
26,243
|
13,122
|
(8,365
|
)
|
-
|
263,041
|
||||||||||
Richard
J. Edwards
|
10,256
|
5,128
|
140
|
-
|
142,463
|
(1) |
These
amounts represent contributions made by such person to the Supplemental
Executive Retirement Plan. These amounts are included in the “Salary”
column for each individual in the Summary Compensation
Table.
|
(2) |
These
amounts represent contributions made by the Company to the Supplemental
Executive Retirement Plan. These amounts are included in the “All Other
Compensation” column for each individual in the Summary Compensation
Table.
|
(3) |
These
amounts consist of appreciation (depreciation) and earnings (loss)
on such
individual’s account under the Supplemental Executive Retirement
Plan.
|
Benefits
and Payments Upon Change-in-Control
|
Named Executive Officers
|
|||
|
Dr.
Michael J. Hartnett
|
(1) | ||
Base
salary
|
$
|
1,551,846
|
||
Incentive
bonus payments (2)
|
656,342
|
|||
Other
payments
|
111,978
|
|||
Stock
options vested and value upon termination (3)
|
788,805
|
|||
Restricted
stock vested and value upon termination (4)
|
1,146,029
|
|||
Excise
tax gross up payments
|
-
|
|||
Total
|
$
|
4,255,000
|
(1)
|
On
July 1, 2005, the Company entered into an employment agreement with
Dr.
Michael J. Hartnett, in connection with his appointment as President
and
CEO of the Company. A copy of the agreement is filed as Exhibit 10.19
to
Amendment No. 4 to the Form S-1 Registration Statement dated August
8,
2005. The employment agreement with Dr. Michael J. Hartnett provides
that
in the event of his termination of employment due to a change-in-control
of the Company, he will generally be entitled to payment of his base
salary for the remainder of the term of the employment agreement
which
ends July 1, 2010 plus a pro rata portion of his annual bonus for
the
fiscal year of the Company during which the termination occurs in
addition
to being entitled to the continuation of all benefits, including
the
Special Benefits, set forth in his employment agreement until July
1,
2010.
|
(2) |
The
actual amount of the incentive bonus payment is not specified in
the
employment agreement and is assumed to be equal to 100% of base salary
for
the applicable fiscal year.
|
(3) |
It
is assumed that all unvested stock options granted to Dr. Michael
J.
Hartnett would become vested upon a change-in-control. In accordance
with
the terms of the 2005 Long Term Incentive Plan, if
there is a change in control of the Company or similar event, the
Compensation Committee may, in its discretion, provide for the vesting
of
a participant’s options on such terms and conditions as it deems
appropriate in such participant’s Award
Agreement.
|
(4) |
It
is assumed that all restrictions associated with restricted stock
grants
have lapsed upon a change of control. In
accordance with the terms of the 2005 Long Term Incentive Plan,
if
there is a change in control the
Compensation Committee may, in its discretion, provide for the lapsing
of
restrictions on a participant’s Restricted Stock on such terms and
conditions as it deems appropriate.
|
Benefits
and Payments Upon Termination
|
Named Executive Officer
|
|||
|
Dr. Michael J. Hartnett
|
(1) | ||
Death
or Disability/Without Cause (1)
|
|
|||
Base
salary
|
$
|
1,367,927
|
||
Incentive
bonus payments
|
656,342
|
|||
Other
payments
|
111,978
|
|||
Stock
options vested and value upon termination (2)
|
788,805
|
|||
Restricted
stock vested and value upon termination (3)
|
1,146,029
|
|||
Total
|
$
|
4,071,081
|
||
With
Cause (4)
|
||||
Base
salary
|
$
|
328,171
|
||
Other
Payments
|
24,884
|
|||
Total
|
$
|
353,055
|
(1) |
The
employment agreement with Dr. Michael J. Hartnett provides that in
the
event of his termination of employment due to his death or disability,
or
without cause, he will generally be entitled to payment of his base
salary
for two years following the date of his death or disability plus
a pro
rata portion of his annual bonus for the fiscal year of the Company
during
which the termination occurs. In addition, in the event of his termination
of employment due to his disability, or without cause, he is entitled
to
the continuation of all benefits, including the Special Benefits,
set
forth in his employment agreement until July 1,
2010.
|
(2) |
It
is assumed that all unvested stock options granted to Dr. Michael
J.
Hartnett would become vested upon his death or disability. In accordance
with the terms of the 2005 Long Term Incentive Plan, the
Compensation Committee may, in its discretion, provide for the vesting
of
a participant’s options on such terms and conditions as it deems
appropriate in the event of an employee’s death or disability.
|
(3) |
It
is assumed that all restrictions associated with restricted stock
grants
have lapsed upon his
death or disability. In accordance with the terms of the 2005 Long
Term
Incentive Plan, the
Compensation Committee may, in its discretion, provide for the
lapsing of restrictions on a participant’s Restricted Stock on
such terms and conditions as it deems appropriate in the event of
an
employee’s death or disability.
|
(4) |
The
employment agreement with Dr. Michael J. Hartnett provides that in
the
event of his termination of employment with cause, he will generally
be
entitled to payment of his base salary in addition to being entitled
to
the continuation of all benefits, including the Special Benefits,
set
forth in his employment agreement for six months following the date
of his
termination of employment.
|
|
Equity Compensation Plan Information
|
|||||||||
|
(A)
|
(B)
|
(C)
|
|||||||
Plan Category
|
Number of securities
to be issued upon
exercise of
outstanding options,
warrants and rights
|
Weighted-average
exercise price of
outstanding options,
warrants and rights
|
Number of securities
remaining available for
future issuance under
equity compensation
plans (excluding
securities reflected in
column (A)
|
|||||||
Equity
compensation plans approved by shareholders
|
1,326,577
|
(1)
|
734,873
|
(2)
|
(1)
|
The
Company does not have equity compensation plans which have not been
approved by the Company’s shareholders.
|
(2)
|
Applies
to the 2005 Long Term Incentive Plan only as no further equity grants
may
be made under the 1998 Stock Option Plan and 2001 Stock Option Plan.
|
|
Fiscal Year
|
||||||
Fee Category
|
March
31,
2007
|
March
29,
2008
|
|||||
Audit
Fees
|
$
|
1,103,500
|
$
|
959,482
|
|||
Audit-Related
Fees
|
—
|
21,500
|
|||||
Tax
Fees
|
85,150
|
114,000
|
|||||
All
Other Fees
|
—
|
—
|
|||||
Total
Fees
|
$
|
1,188,650
|
$
|
1,094,982
|
|
By
order of the Board of Directors,
|
|
|
|
Corporate
Secretary
|
Dated:
July 28, 2008
|
|
(i) |
the
integrity of the Company’s financial
statements;
|
(ii) |
the
independent auditor’s qualifications and
independence;
|
(iii) |
the
performance of the Company’s internal audit function and independent
auditors;
|
(iv) |
the
Company’s compliance with legal and regulatory requirements;
and
|
(v) |
the
preparation of an audit committee report as required by the Securities
and
Exchange Commission (the “SEC”) to be included in the Company’s annual
proxy statement.
|
(vi) |
Committee
pre-approval of audit and non-audit services will not be required
if the
engagement for the services is entered into pursuant to pre-approval
policies and procedures established by the Committee regarding the
Company’s engagement of the independent auditor, provided the policies and
procedures are detailed as to the particular service, the Committee
is
informed of each service provided and such policies and procedures
do not
include delegation of the Committee’s responsibilities under the Exchange
Act to the Company’s management.
|
(vii) |
Committee
pre-approval of non-audit services (other than review and attestation
services) also will not be required if such services fall within
available
exceptions established by the SEC.
|
(viii)
|
|
The
Committee shall obtain and review a report prepared by the independent
auditor describing (a) the independent auditing firm’s internal
quality-control procedures, (b) any material issues raised by the
most recent internal quality-control review or peer review of the
independent auditing firm, or by any inquiry or investigation by
governmental or professional authorities, within the preceding five
years,
respecting one or more independent audits carried out by the independent
auditing firm, and any steps taken to deal with any such issues and
(c) all relationships between the independent auditor and the
Company.
|
(ix)
|
|
The
Committee shall obtain and review a formal written statement prepared
by
the independent auditor describing the fees billed in each of the
last two
fiscal years in each of the categories required to be disclosed in
the
Company’s annual proxy statement.
|
(x)
|
|
The
Committee shall discuss with the independent auditor its independence
from
the Company, and obtain and review a written statement prepared by
the
independent auditor describing all relationships between the independent
auditor and the Company, consistent with Independence Standards Board
Standard 1, and consider the impact that any relationships or services
may
have on the objectivity and independence of the independent
auditor.
|
(xi)
|
|
The
Committee shall review and evaluate the qualifications, performance
and
independence of the lead partner of the independent
auditor.
|
(xii)
|
|
The
Committee shall consider whether, in order to assure continuing auditor
independence, the Company should adopt a regular rotation of the
independent audit firm.
|
(xiii)
|
|
The
Committee shall, if applicable, consider whether the independent
auditor’s
provision of any permitted non-audit services to the Company is compatible
with maintaining the independence of the independent
auditor.
|
(xiv) |
The
Committee shall discuss with the independent auditor the matters
required
to be discussed by Statement on Auditing Standards No. 61,
“Communication with Audit Committees,” as then in
effect.
|
(xv) |
The
Committee shall review with the independent auditor any problems
or
difficulties the independent auditor may have encountered during
the
course of the audit work, including any restrictions on the scope
of
activities or access to required information or any significant
disagreements with management and management’s responses to such matters.
Among the items that the Committee should consider reviewing with
the
independent auditor are: (i) any accounting adjustments that
were noted or proposed by the auditor but were “passed” (as immaterial or
otherwise); (ii) any communications between the audit team and the
independent auditor’s national office respecting auditing or accounting
issues presented by the engagement; and (iii) any “management” or
“internal control” letter issued, or proposed to be issued, by the
independent auditor to the Company.
|
(i) |
developing
and approving the Company’s executive compensation
philosophy;
|
(ii) |
setting
goals and objectives for the CEO, evaluating the CEO’s performance in
light of these goals, and determining the CEO’s compensation based upon
this evaluation;
|
(iii) |
approving
the compensation structure for the other executive officers and reviewing
the CEO’s recommendations with respect to executive officer
compensation;
|
(iv) |
making
recommendations to the Board with respect to director
compensation;
|
(v) |
overseeing
CEO and executive succession planning and development;
and
|
(vi) |
fulfilling
any other responsibilities set forth in this Charter and any additional
duties that may be assigned to the Committee by the Board from time
to
time.
|
i) |
an
appropriate peer group of companies for the purposes of comparing
compensation levels and practices;
and
|
ii) |
key
measures that the Committee will use in assessing performance for
the
purposes of incentive compensation awards to the CEO and other members
of
the senior management team.
|
(vii)
|
|
establishing
criteria and qualifications for Board members, identifying individuals
qualified to serve as Board members, and recommending to the Board
annually a slate of nominees to be forwarded to the stockholders
for
election at the Annual Meeting for all Board seats subject to stockholder
vote;
|
(viii)
|
|
making
recommendations to the Board with respect to the membership and
chairmanship of each of the Board committees and reviewing the composition
and structure of the Board committees on a regular
basis;
|
(ix)
|
|
developing
the Company’s Corporate Governance Guidelines in accordance with the
requirements of the NASDAQ Stock Market (“NASDAQ”), recommending these to
the Board for approval, reviewing them on a regular basis and recommending
updates or modifications to them, as appropriate;
|
(x)
|
|
developing
and leading the annual performance evaluation of the Board, conducting
an
annual evaluation of the Committee and coordinating the annual evaluations
of each of the other Board committees led by the respective Committee
Chairs; and
|
(xi)
|
|
fulfilling
any other responsibilities set forth in this Charter and any additional
duties that may be assigned to the Committee by the Board from time
to
time.
|
|
For
|
|
Withhold
|
|
|
o
|
|
o
|
|
|
For
|
|
Withhold
|
|
|
o
|
|
o
|
|
|
For
|
|
Withhold
|
|
|
o
|
|
o
|
|
|
For
|
|
Against
|
|
Abstain
|
|
|
o
|
|
o
|
|
o
|
|
Signature
of Shareholder
|
|
|
Date:
|
|
|
Signature
of Shareholder
|
|
|
Date:
|
|
|
PROXY
|
RBC
BEARINGS INCORPORATED
|
PROXY
|
COMMENTS/ADDRESS
CHANGE:
|
|
|
|
|
|
|
|